The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Latent TB Infection Testing Market Research Report 2025

Global Latent TB Infection Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1911221

No of Pages : 86

Ask Your Query
Synopsis
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
The global Latent TB Infection Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Latent TB Infection Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Latent TB Infection Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Latent TB Infection Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Latent TB Infection Testing include Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd. and Qiagen N.V., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Latent TB Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent TB Infection Testing.
Report Scope
The Latent TB Infection Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Latent TB Infection Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent TB Infection Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
Pharmstandard (Generium Pharmaceutical)
Sanofi S.A./Sanofi Pasteur Ltd.
Statens Serum Institut (SSI)
Autoimmun Diagnostika (AID) GmbH
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
Immunoshop India Pvt. Ltd.
Qiagen N.V.
Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
SD Biosensor, Inc.
Segment by Type
Mantoux Test / Tuberculin Skin Test (TST)
Interferon-Gamma Release Assay (IGRA)
Segment by Application
Hospitals
Public and Student Health
Physician Offices and Clinics
Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent TB Infection Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent TB Infection Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mantoux Test / Tuberculin Skin Test (TST)
1.2.3 Interferon-Gamma Release Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent TB Infection Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Public and Student Health
1.3.4 Physician Offices and Clinics
1.3.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent TB Infection Testing Market Perspective (2019-2030)
2.2 Latent TB Infection Testing Growth Trends by Region
2.2.1 Global Latent TB Infection Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Latent TB Infection Testing Historic Market Size by Region (2019-2024)
2.2.3 Latent TB Infection Testing Forecasted Market Size by Region (2025-2030)
2.3 Latent TB Infection Testing Market Dynamics
2.3.1 Latent TB Infection Testing Industry Trends
2.3.2 Latent TB Infection Testing Market Drivers
2.3.3 Latent TB Infection Testing Market Challenges
2.3.4 Latent TB Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent TB Infection Testing Players by Revenue
3.1.1 Global Top Latent TB Infection Testing Players by Revenue (2019-2024)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2019-2024)
3.2 Global Latent TB Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent TB Infection Testing Revenue
3.4 Global Latent TB Infection Testing Market Concentration Ratio
3.4.1 Global Latent TB Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent TB Infection Testing Revenue in 2023
3.5 Latent TB Infection Testing Key Players Head office and Area Served
3.6 Key Players Latent TB Infection Testing Product Solution and Service
3.7 Date of Enter into Latent TB Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent TB Infection Testing Breakdown Data by Type
4.1 Global Latent TB Infection Testing Historic Market Size by Type (2019-2024)
4.2 Global Latent TB Infection Testing Forecasted Market Size by Type (2025-2030)
5 Latent TB Infection Testing Breakdown Data by Application
5.1 Global Latent TB Infection Testing Historic Market Size by Application (2019-2024)
5.2 Global Latent TB Infection Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Latent TB Infection Testing Market Size (2019-2030)
6.2 North America Latent TB Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Latent TB Infection Testing Market Size by Country (2019-2024)
6.4 North America Latent TB Infection Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent TB Infection Testing Market Size (2019-2030)
7.2 Europe Latent TB Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Latent TB Infection Testing Market Size by Country (2019-2024)
7.4 Europe Latent TB Infection Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent TB Infection Testing Market Size (2019-2030)
8.2 Asia-Pacific Latent TB Infection Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Latent TB Infection Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Latent TB Infection Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent TB Infection Testing Market Size (2019-2030)
9.2 Latin America Latent TB Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Latent TB Infection Testing Market Size by Country (2019-2024)
9.4 Latin America Latent TB Infection Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent TB Infection Testing Market Size (2019-2030)
10.2 Middle East & Africa Latent TB Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Latent TB Infection Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Latent TB Infection Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Detail
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Introduction
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2019-2024)
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Development
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Detail
11.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Introduction
11.2.4 Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2019-2024)
11.2.5 Pharmstandard (Generium Pharmaceutical) Recent Development
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Detail
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Introduction
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2019-2024)
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Recent Development
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Detail
11.4.2 Statens Serum Institut (SSI) Business Overview
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Introduction
11.4.4 Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2019-2024)
11.4.5 Statens Serum Institut (SSI) Recent Development
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Detail
11.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Introduction
11.5.4 Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2019-2024)
11.5.5 Autoimmun Diagnostika (AID) GmbH Recent Development
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Detail
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Introduction
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2019-2024)
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Development
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Detail
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Introduction
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2019-2024)
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Development
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Detail
11.8.2 Immunoshop India Pvt. Ltd. Business Overview
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Introduction
11.8.4 Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2019-2024)
11.8.5 Immunoshop India Pvt. Ltd. Recent Development
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Detail
11.9.2 Qiagen N.V. Business Overview
11.9.3 Qiagen N.V. Latent TB Infection Testing Introduction
11.9.4 Qiagen N.V. Revenue in Latent TB Infection Testing Business (2019-2024)
11.9.5 Qiagen N.V. Recent Development
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Detail
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Introduction
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2019-2024)
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Development
11.11 SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Detail
11.11.2 SD Biosensor, Inc. Business Overview
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Introduction
11.11.4 SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2019-2024)
11.11.5 SD Biosensor, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Latent TB Infection Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Global Latent TB Infection Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Latent TB Infection Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Latent TB Infection Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Latent TB Infection Testing Market Share by Region (2019-2024)
Table 8. Global Latent TB Infection Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Latent TB Infection Testing Market Share by Region (2025-2030)
Table 10. Latent TB Infection Testing Market Trends
Table 11. Latent TB Infection Testing Market Drivers
Table 12. Latent TB Infection Testing Market Challenges
Table 13. Latent TB Infection Testing Market Restraints
Table 14. Global Latent TB Infection Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Latent TB Infection Testing Market Share by Players (2019-2024)
Table 16. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2023)
Table 17. Ranking of Global Top Latent TB Infection Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Latent TB Infection Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Latent TB Infection Testing Product Solution and Service
Table 21. Date of Enter into Latent TB Infection Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent TB Infection Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Latent TB Infection Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Latent TB Infection Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Latent TB Infection Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Latent TB Infection Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Latent TB Infection Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Latent TB Infection Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Latent TB Infection Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Latent TB Infection Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Latent TB Infection Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Latent TB Infection Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Latent TB Infection Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Latent TB Infection Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Latent TB Infection Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Latent TB Infection Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Latent TB Infection Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Latent TB Infection Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Latent TB Infection Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Latent TB Infection Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Detail
Table 47. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
Table 48. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product
Table 49. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 50. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Development
Table 51. Pharmstandard (Generium Pharmaceutical) Company Detail
Table 52. Pharmstandard (Generium Pharmaceutical) Business Overview
Table 53. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product
Table 54. Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 55. Pharmstandard (Generium Pharmaceutical) Recent Development
Table 56. Sanofi S.A./Sanofi Pasteur Ltd. Company Detail
Table 57. Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
Table 58. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product
Table 59. Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 60. Sanofi S.A./Sanofi Pasteur Ltd. Recent Development
Table 61. Statens Serum Institut (SSI) Company Detail
Table 62. Statens Serum Institut (SSI) Business Overview
Table 63. Statens Serum Institut (SSI) Latent TB Infection Testing Product
Table 64. Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 65. Statens Serum Institut (SSI) Recent Development
Table 66. Autoimmun Diagnostika (AID) GmbH Company Detail
Table 67. Autoimmun Diagnostika (AID) GmbH Business Overview
Table 68. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product
Table 69. Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 70. Autoimmun Diagnostika (AID) GmbH Recent Development
Table 71. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Detail
Table 72. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
Table 73. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product
Table 74. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 75. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Development
Table 76. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Detail
Table 77. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
Table 78. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product
Table 79. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 80. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Development
Table 81. Immunoshop India Pvt. Ltd. Company Detail
Table 82. Immunoshop India Pvt. Ltd. Business Overview
Table 83. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product
Table 84. Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 85. Immunoshop India Pvt. Ltd. Recent Development
Table 86. Qiagen N.V. Company Detail
Table 87. Qiagen N.V. Business Overview
Table 88. Qiagen N.V. Latent TB Infection Testing Product
Table 89. Qiagen N.V. Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 90. Qiagen N.V. Recent Development
Table 91. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Detail
Table 92. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
Table 93. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product
Table 94. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 95. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Development
Table 96. SD Biosensor, Inc. Company Detail
Table 97. SD Biosensor, Inc. Business Overview
Table 98. SD Biosensor, Inc. Latent TB Infection Testing Product
Table 99. SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2019-2024) & (US$ Million)
Table 100. SD Biosensor, Inc. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Latent TB Infection Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Latent TB Infection Testing Market Share by Type: 2023 VS 2030
Figure 3. Mantoux Test / Tuberculin Skin Test (TST) Features
Figure 4. Interferon-Gamma Release Assay (IGRA) Features
Figure 5. Global Latent TB Infection Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Latent TB Infection Testing Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Public and Student Health Case Studies
Figure 9. Physician Offices and Clinics Case Studies
Figure 10. Others (Military, Correctional Facilities, Chronic Care Homes, and Others) Case Studies
Figure 11. Latent TB Infection Testing Report Years Considered
Figure 12. Global Latent TB Infection Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Latent TB Infection Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Latent TB Infection Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Latent TB Infection Testing Market Share by Players in 2023
Figure 16. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2023
Figure 18. North America Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Latent TB Infection Testing Market Share by Country (2019-2030)
Figure 20. United States Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Latent TB Infection Testing Market Share by Country (2019-2030)
Figure 24. Germany Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Latent TB Infection Testing Market Share by Region (2019-2030)
Figure 32. China Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Latent TB Infection Testing Market Share by Country (2019-2030)
Figure 40. Mexico Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Latent TB Infection Testing Market Share by Country (2019-2030)
Figure 44. Turkey Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Latent TB Infection Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 47. Pharmstandard (Generium Pharmaceutical) Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 48. Sanofi S.A./Sanofi Pasteur Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 49. Statens Serum Institut (SSI) Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 50. Autoimmun Diagnostika (AID) GmbH Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 51. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 52. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 53. Immunoshop India Pvt. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 54. Qiagen N.V. Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 55. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 56. SD Biosensor, Inc. Revenue Growth Rate in Latent TB Infection Testing Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock